Kahn Swick & Foti & ADMA Biologics

Kahn Swick & Foti: Kahn Swick & Foti is one of the law firms representing investors in the class action, actively soliciting clients and reminding them of the lead plaintiff deadline. The firm stands to gain from a successful settlement.

ADMA Biologics: ADMA Biologics is the defendant in the securities class action, accused of making false and misleading statements. The lawsuit and allegations have led to a significant drop in its stock price and could result in substantial financial penalties and reputational harm.

Kahn Swick & Foti: Kahn Swick & Foti is a law firm that has notified investors of a class action securities lawsuit against ADMA Biologics.

ADMA Biologics: ADMA Biologics is the primary subject of the class action lawsuits and investigations due to allegations of channel stuffing, undisclosed related-party transactions, and misleading revenue growth, which caused its stock price to decline significantly.